Imisopasem manganese
Alternative Names: M 40403; Superoxide dismutase mimic - MetaPhoreLatest Information Update: 27 May 2008
At a glance
- Originator MetaPhore Pharmaceuticals
- Developer ActivBiotics; MetaPhore Pharmaceuticals
- Class Analgesics; Anti-inflammatories; Anti-ischaemics; Macrocyclic compounds; Oxidoreductases; Small molecules
- Mechanism of Action Superoxide dismutase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Cancer pain; Pain; Postoperative pain; Stomatitis
Most Recent Events
- 02 Apr 2008 ActivBiotics sells its intellectual property assets including drug product candidates
- 07 Mar 2008 Imisopasem manganese received Orphan Drug status for Stomatitis in USA
- 05 Feb 2008 Imisopasem manganese received Orphan Drug status for Stomatitis in European Union